Gerald R. Fink

President at The Genetics Society of America, Inc.

Gerald R. Fink

Gerald R. Fink

President at The Genetics Society of America, Inc.

Overview
Career Highlights

The Genetics Society of America, Inc.
Boragen, Inc.
Immunexcite, Inc.

RelSci Relationships

3418

Number of Boards

10

Birthday

07/01/1940

Age

81

Contact Data
Trying to get in touch with Gerald R. Fink? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Gerald R. Fink likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Chief Academic Officer at Minerva Project, Inc.

Relationship likelihood: Strong

Professor, Director of Jack H. Skirball Center for Chemical Biology & Proteomics & Arthur & Julie Woodrow Chair at The Salk Institute for Biological Studies

Relationship likelihood: Strong

President Emeritus at California Institute of Technology

Relationship likelihood: Strong

Professor, Director-Vision Center Laboratory & Conrad T. Prebys Chair in Vision Research at The Salk Institute for Biological Studies

Relationship likelihood: Strong

Co-Founder at Genetics Institute LLC

Relationship likelihood: Strong

Chairman-Molecular Biology Department at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Professor Emeritus, Business Administration at The Scripps Research Institute - California

Relationship likelihood: Strong

Chairman-Pharmacology Department at Yale University - Yale School of Medicine

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Gerald R. Fink
Potential Connections via
Relationship Science
You
Gerald R. Fink
President at The Genetics Society of America, Inc.
Education
PhD in Genetics

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

Memberships
Member
Current

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Associate Member

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Member
Prior

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
Faculty Member
Prior

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

Faculty Member, Molecular Mycology Course
Prior

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

Professor
Current

Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic biomedical research. By cultivating a deeply collaborative culture and enabling the pursuit of bold, creative inquiry, Whitehead fosters paradigm-shifting scientific achievement. For more than 30 years, Whitehead faculty have delivered breakthroughs that have transformed our understanding of biology and accelerated development of therapies for such diseases as Alzheimer’s, Parkinson’s, diabetes, and certain cancers. Located in Cambridge, Massachusetts, Whitehead Institute was founded in 1982 by businessman and philanthropist Edwin C. “Jack” Whitehead.

Boards & Committees
Member, Scientific Advisory Board
Current

GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH.

Member, Scientific Advisory Board
Prior

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Member, Scientific Advisory Board
Prior

Allylix, Inc. develops terpene products for flavor and fragrance, food ingredients, pharmaceuticals, agricultural, and biofuels markets. The company was founded by Joseph Chappel, Thomas E. Jurgensen, and Joseph Noel on January 4, 2005 and is headquartered in Lexington, KY.

Member, International Board
Current

The Weizmann Institute of Science is one of the world’s leading multidisciplinary research institutions. Hundreds of scientists, laboratory technicians and research students working on its lushly landscaped campus embark daily on fascinating journeys into the unknown, seeking to improve our understanding of nature and our place within it. Lettuce fieldGuiding these scientists is the spirit of inquiry so characteristic of the human race. It is this spirit that propelled humans upward along the evolutionary ladder, helping them reach their utmost heights. It prompted humankind to pursue agriculture, learn to build lodgings, invent writing, harness electricity to power emerging technologies, observe distant galaxies, design drugs to combat various diseases, develop new materials and decipher the genetic code embedded in all the plants and animals on Earth. The quest to maintain this increasing momentum compels Weizmann Institute scientists to seek out places that have not yet been reached by the human mind. What awaits us in these places? No one has the answer to this question. But one thing is certain – the journey fired by curiosity will lead onward to a better future. Groundbreaking medical and technological applications that have emerged from basic research conducted by Weizmann Institute scientists include: Amniocentesis, a prenatal diagnostic test for the fetus neonatal Sophisticated laser systems for high-precision diamond cutting A method for growing hybrid seeds that prevents the transmission of disease from one generation to the next and helps protect edible plants from pests Affinity chromatography, a key tool for purifying biological materials in the biotechnology industry Living polymerization, one of the most fundamental techniques of the modern polymer industry For solving the structure of the ribosome, the cell’s protein factory, and revealing its means of action, the Institute’s Prof. Ada Yonath was awarded a Nobel Prize in Chemistry. Her research should speed the development of antibiotic drugs that are more efficient, especially against antibiotic-resistant strains

Member, Board of Trustees
Prior - 2021

The Howard Hughes Medical Institute (HHMI) is a nonprofit medical research organization that ranks as one of the nation’s largest philanthropies. HHMI plays a prominent role in advancing biomedical research and science education in the United States. Founded in 1953 by aviator and industrialist Howard R. Hughes, HHMI is headquartered in Chevy Chase, Maryland, and employs more than 3,000 individuals across the U.S. HHMI has an endowment of $16.1 billion of which the Institute spent $800 million for research and distributed $119 million in grant support for science education in fiscal year 2012

Chair, Board of Directors
Prior

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Investments
Details Hidden

Boragen, Inc. engages in the design and developemnt of novel solutions targeting needs in crop protection, animal health and human health. It specializes in chemistry, research, and biotechnology. The company was founded by Stephen J. Benkovic, Gerald R. Fink, Lucy Shapiro, Paul R. Schimmel and C. Tony Liu in 2015 and is headquartered in Durham, NC.

Details Hidden

ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerald R. Fink. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerald R. Fink's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerald R. Fink.